Evaluating Effectiveness of Remdesivir on Intubation Rates in Patients Hospitalized with Severe Covid-19 at Tuba City Regional Health Care Corporation (TCRHCC)

TCRHCC is a Joint Commission accredited health center providing services to more than 15,000 patients within 6,000 square mile area of the Navajo and Hopi Reservations. As of April 20, 2021, TCRHCC was heavily burdened by COVID-19 with over 5,000 positive cases which is 16.7% of the Navajo Nation COVID-19 positive cases. On May 21, 2020, TCRHCC Pharmacy and Therapeutics Committee (P&T) added remdesivir on restrictedformulary as a treatment option for hospitalized patients with severe COVID-19. This study has been established to evaluate rate of intubation in COVID-19 patients before and after the training, TCRHCC remdesivir criteria compliance, hospitalized COVID-19 patient discharge to home, and transfer out tohigher level of care.